Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

Cigna and Primary Partners announce new collaborative care initiative

Cigna Corporation, a health insurance service company, and Primary Partners LLC, a physician owned and managed accountable care organization, have launched a collaborative care initiative to improve patient access to health care and enhance care coordination...more >>

Asterias Biotherapeutics Q3 net loss down

Asterias Biotherapeutics, Inc., a biotechnology company, has reported that net loss for the third quarter ended September 30, 2014 was $1.68 million, or $0.05 loss per share, compared to a net loss of $2.67 million, or $51.62 loss per share, for the same quarter ended September 30, 2013...more >>

Halozyme Therapeutics Q3 net loss up

Halozyme Therapeutics, Inc., a biopharmaceutical company, has reported that net loss for the third quarter ended September 30, 2014 was $20.28 million, or $0.16 loss per share, compared to a net loss of $19.29 million, or $0.17 loss per share, for the same quarter ended September 30, 2013...more >>

Rhoen Klinikum reports lower Q3 income, provides guidance for 2015

Rhoen Klinikum AG, a provider of health care services, has reported that consolidated income attributable to the shareholders for the third quarter ended September 30, 2014 was E12.31 million, or E0.09 per share, compared to E17.09 million, or E0.12 per share, for the same quarter ended September 30, 2013. For 2015, the company expects revenues to be in the range of E1.06 billion to E1.12 billion...more >>

More headlines

OP Financial to build new hospital network in Finland under Pohjola brand
Published 20 November 2014 - MarketLine

Biotest receives marketing authorization for human albumin solution in China
Published 20 November 2014 - MarketLine

Nuvo Research reports net income for Q3
Published 20 November 2014 - MarketLine

Osiris Therapeutics reports net income for Q3
Published 20 November 2014 - MarketLine

Fibrocell Science Q3 net loss down
Published 20 November 2014 - MarketLine

PDL BioPharma Q3 net income up
Published 20 November 2014 - MarketLine

InfuSystem Q3 net income up
Published 20 November 2014 - MarketLine

Hemispherx Biopharma Q3 net loss down
Published 20 November 2014 - MarketLine

Idera Pharmaceuticals Q3 net loss up
Published 20 November 2014 - MarketLine

GTx Q3 net loss down
Published 20 November 2014 - MarketLine

TOHO reports lower H1 net income, provides annual outlook
Published 20 November 2014 - MarketLine

Browse all news >>